Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins

被引:45
作者
Bétis, F
Brest, P
Hofman, V
Guignot, J
Kansau, I
Rossi, B
Servin, A
Hofman, P
机构
[1] Fac Med, INSERM, U364, IFR 50, F-06107 Nice 02, France
[2] Fac Med, Anat Pathol Lab, F-06107 Nice, France
[3] Fac Pharm Paris 11, INSERM, U510, F-92296 Chatenay Malabry, France
关键词
D O I
10.1128/IAI.71.4.1774-1783.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ulcerative colitis and Crohn's disease are inflammatory bowel diseases thought to involve strains of Escherichia coli. We report here that two wild-type Afa/Dr diffusely adhering E. coli (DAEC) strains, C1845 and IH11128, which harbor the fimbrial F1845 adhesin and the Dr hemegglutinin, respectively, and the E. coli laboratory strain HB101, transformed with the pSSS1 plasmid to produce Afa/Dr F1845 adhesin, all induced interleukin-8 (IL-8) production and transepithelial migration of polymorphonuclear leukocytes (PMNL) in polarized monolayers of the human intestinal cell line T84 grown on semipermeable filters. We observed that after PMNL migration, expression of decay-accelerating factor (DAF, or CD55), the brush border-associated receptor for Afa/Dr adhesins, was strongly enhanced, increasing the adhesion of Afa/Dr DAEC bacteria. When examining the mechanism by which DAF expression was enhanced, we observed that the PMNL transepithelial migration induced epithelial synthesis of tumor necrosis factor alpha and IL-1beta which in turn promoted the upregulation of DAF.
引用
收藏
页码:1774 / 1783
页数:10
相关论文
共 75 条
  • [1] Cross-talk between caveolae and glycosylphosphatidylinositol-rich domains
    Abrami, L
    Fivaz, M
    Kobayashi, T
    Kinoshita, T
    Parton, RG
    van der Goot, FG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (33) : 30729 - 30736
  • [2] Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells
    Andoh, A
    Fujiyama, Y
    Sumiyoshi, K
    Sakumoto, H
    Okabe, H
    Bamba, T
    [J]. IMMUNOLOGY, 1997, 90 (03) : 358 - 363
  • [3] Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells
    Andoh, A
    Fujiyama, Y
    Sumiyoshi, K
    Sakumoto, H
    Bamba, T
    [J]. GASTROENTEROLOGY, 1996, 111 (04) : 911 - 918
  • [4] Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-κB and MAP kinase pathways and the upregulated expression of interleukin 8
    Berin, MC
    Darfeuille-Michaud, A
    Egan, LJ
    Miyamoto, Y
    Kagnoff, MF
    [J]. CELLULAR MICROBIOLOGY, 2002, 4 (10) : 635 - 647
  • [5] Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells
    BernetCamard, MF
    Coconnier, MH
    Hudault, S
    Servin, AL
    [J]. INFECTION AND IMMUNITY, 1996, 64 (06) : 1918 - 1928
  • [6] Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines
    BernetCamard, MF
    Coconnier, MH
    Hudault, S
    Servin, AL
    [J]. GUT, 1996, 38 (02) : 248 - 253
  • [7] Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract
    Berstad, AE
    Brandtzaeg, P
    [J]. GUT, 1998, 42 (04) : 522 - 529
  • [8] MOLECULAR CHARACTERIZATION OF A FIMBRIAL ADHESIN, F1845, MEDIATING DIFFUSE ADHERENCE OF DIARRHEA-ASSOCIATED ESCHERICHIA-COLI TO HEP-2 CELLS
    BILGE, SS
    CLAUSEN, CR
    LAU, W
    MOSELEY, SL
    [J]. JOURNAL OF BACTERIOLOGY, 1989, 171 (08) : 4281 - 4289
  • [9] Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF,CD55) and membrane cofactor protein (MCP,CD46) on a human colonic adenocarcinoma cell line
    Bjorge, L
    Jensen, TS
    Matre, R
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 42 (03) : 185 - 192
  • [10] Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x